Effect of therapeutic plasma concentrations of non-steroidal anti-inflammatory drugs on the production of reactive oxygen species by activated rat neutrophils

Brazilian Journal of Medical and Biological Research

Volumn 38, Issue 4, 2005, Pages 543-551

  Paino, I M M ^a   Ximenes, V F ^a   da Fonseca, L M ^a   Kanegae, M P P ^a   Khalil, N M ^a   Brunetti, I L ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Chemiluminescence; HYpochlorous acid; Myeloperoxidase; Neutrophils; Non steroidal anti inflammatory drugs; Reactive oxygen species

Indexed keywords

DICLOFENAC; HYPOCHLOROUS ACID; INDOMETACIN; LUCIGENIN; LUMINOL; MYELOPEROXIDASE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHORBOL 12 ACETATE 13 MYRISTATE; PIROXICAM; REACTIVE OXYGEN METABOLITE; TENOXICAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL STIMULATION; CHEMOLUMINESCENCE; CHLORINATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; INCUBATION TEMPERATURE; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; NEUTROPHIL; NONHUMAN; OXIDATION; RAT; SYNTHESIS;

ANIMALIA;

EID: 18844380748     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2005000400007     Document Type: Article

References (40)

1. Dahlgren C & Karlsson A (1999). Respiratory burst in human neutrophils. Journal of Immunological Methods, 232: 3-14.
2. Babior BM (2000). Phagocytes and oxidative stress. American Journal of Medicine, 109: 33-44.
3. Hampton MB, Kettle AJ & Winterbourn CC (1998). Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood, 92: 3007-3017.
4. Podrez EA, Abu-Soud HM & Hazen SL (2000). Myeloperoxidase-generated oxidants and atherosclerosis. Free Radical Biology and Medicine, 28: 1717-1725.
5. Lapenna D & Cuccurullo F (1996). Hypochlorous acid and its pharmacological antagonism: an update picture. General Pharmacology, 27: 1147-1154.
6. Heinecke JW, Li W, Mueller DM, Bohrer A & Turk J (1994). Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes. Biochemistry, 33: 10127-10136.
7. Spickett CM, Jerlich A, Panasenko OM, Arnhold J, Pitt AR, Stelmaszynska T & Schaur RJ (2000). The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids. Acta Biochimica Polonica, 47: 889-899.
8. Domigan NM, Charlton TS, Duncan MW, Winterbourn CC & Kettle AJ (1995). Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. Journal of Biological Chemistry, 270: 16542-16548.
9. Carr AC, Decker EA, Park Y & Frei B (2001). Comparison of low-density lipoprotein modification by myeloperoxidase-derived hypochlorous and hypobromous acids. Free Radical Biology and Medicine, 31: 62-72.
10. Chapman AL, Winterbourn CC, Brennan SO, Jordan TW & Kettle AJ (2003). Characterization of non-covalent oligomers of proteins treated with hypochlorous acid. Biochemical Journal, 375: 33-40.
11. Henrotin YE, Bruckner P & Pujol JP (2003). The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis and Cartilage, 10: 747-755.
12. Turpaev KT (2002). Reactive oxygen species and regulation of gene expression. Biochemistry, 3: 292-299.
13. Kast RE (2000). Non-steroidal anti-inflammatory drugs might also be pro-inflammatory by increasing tumor necrosis factor. Biomedical Pharmacotherapy, 54: 168-169.
14. Kast RE (2000). Tumor necrosis factor has positive and negative self regulatory feed back cycles centered around cAMP. International Journal of Immunopharmacology, 22: 1001-1006.
15. Ju C & Uetrecht JP (1998). Oxidation of a metabolite of indomethacin (desmethyldeschlorobenzoylindomethacin) to reactive intermediates by activated neutrophils, hypochlorous acid, and the myeloperoxidase system. Drug Metabolism and Disposition, 26: 676-680.
16. Jacobs JWG & Bijlsma JWJ (1997). NSAIDs: a critical appraisal. Netherlands Journal of Medicine, 51: 198-204.
17. Babior MB & Cohen HJ (1981). Measurement of neutrophil function: phagocytosis, degranulation, the respiratory burst and bactericidal killing. In: Cline MJ (Editor), Methods in Hematology: Leucocyte Function. Churchill Livingstone, New York.
18. Dorfman LE & Wacker WEC (1963). Serum lactic dehydrogenase activity: an analytical assessment of current assays. Clinical Chemistry, 9: 391-399.
19. Parij N, Nagy AM, Fondu P & Neve J (1998). Effects of non-steroidal anti-inflammatory drugs on the luminol and lucigenin amplified chemiluminescence of human neutrophils. European Journal of Pharmacology, 352: 299-305.
20. Harrison JE & Schultz J (1976). Studies on the chlorinating activity of myeloperoxidase. Journal of Biological Chemistry, 251: 1371-1374.
21. Ching T, Dejong J & Bast A (1994). A method for screening hypochlorous acid scavengers by inhibition of the oxidation of 5-thio-2-nitrobenzoic acid: application to anti-asthmatic drugs. Analytical Biochemistry, 218: 377-381.
22. Insel PA (1991). Substâncias analgésicas, antipiréticas e antiinflamatórias. Drogas empregadas no tratamento da artrite reumatóide e da gota. In: Gilman AG, Rall TW, Nies AS & Taylor P (Editors), Goodman & Gilman. As Bases Farmacológicas da Terapêutica. Guanabara & Koogan, Rio de Janeiro, RJ, Brazil.
23. Korolkovas A (1999). Dicionário Terapêutico Guanabara 1999/2000. Guanabara-Koogan, Rio de Janeiro, RJ, Brazil.
24. Gennaro AR (2000). Non steroidal antiinflammatory drugs. In: Limmer D (Editor), Remington: The Science and Practice of Pharmacy. Lippincott Williams & Wilkins, Philadelphia, PA, USA.
25. 2-Cl system of neutrophils by indomethacin and other non-steroidal anti-inflammatory drugs. Biochemical Pharmacology, 41: 975-984.
26. Kataoka M, Tonooka K, Ando T, Imai K & Aimoto T (1997). Hydroxyl radical scavenging activity of nonsteroidal anti-inflammatory drugs. Free Radical Research, 27: 419-427.
27. Faulkner K & Fridolvich I (1993). Luminol and lucigenin as detectors for superoxide. Free Radical Biology and Medicine, 15: 447-451.
28. Vasquez-Vivar J, Hogg N, Pritchard Jr KA, Martasek P & Kalyanaraman B (1997). Superoxide anion formation from lucigenin: an electron spin resonance spin-trapping study. FEBS Letters, 403: 127-130.
29. Li Y, Zhu H, Kuppusamy P, Roubaud V, Zweier JL & Trush MA (1998). Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. Journal of Biological Chemistry, 273: 2015-2023.
30. Dodeigne C, Thumus L & Lejeune R (2000). Chemiluminescence as diagnostic tool. A review. Talanta, 51: 415-439.
31. Allen RC, Dale DC & Taylor Jr FB (2000). Blood phagocyte luminescence: gauging systemic immune activation. Methods in Enzymology, 305: 591-609.
32. Al-Arfaj AS, Alballa SR, Mustafa AA, Al-Tuwaijri AS, Al-Dalaan AN & Al-Humayyd MS (2004). Effect of diclofenac alone or in combination with alpha-tocopherol on the oxidative activity of polymorphonuclear leukocytes in healthy and osteoarthritic individuals. Saudi Medical Journal, 25: 198-203.
33. Bekesi G, Kakucs R, Sandor J et al. (2001). Plasma concentration of myeloperoxidase enzyme in pre- and post-climacterial people: related superoxide anion generation. Experimental Gerontology, 37: 137-148.
34. Kato Y, Nagao A, Terao J & Osawa T (2003). Inhibition of myeloperoxidase-catalyzed tyrosylation by phenolic antioxidants in vitro. Bioscience, Biotechnology, and Biochemistry, 67: 1136-1139.
35. Ghibaudi E & Laurenti E (2003). Unraveling the catalytic mechanism of lactoperoxidase and myeloperoxidase. European Journal of Biochemistry, 270: 4403-4412.
36. Hartfield PJ & Robinson JM (1998). Arachidonic acid activates NADPH oxidase by a direct, calmodulin-regulated mechanism. Prostaglandins and Other Lipid Mediators, 56: 1-6.
37. 4 stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. Journal of Biological Chemistry, 277: 8572-8578.
38. Schieven GL, de Fex H & Stephenson L (2002). Hypochlorous acid activates tyrosine phosphorylation signal pathways leading to calcium signaling and TNFalpha production. Antioxidants and Redox Signaling, 4: 501-507.
39. Galati G, Tafazoli S, Sabzevari O, Chan TS & O'Brien PJ (2002). Idiosyncratic NSAID drug induced oxidative stress. Chemico-Biological Interactions, 142: 25-41.
40. Miyamoto G, Zahid N & Uetrecht JP (1997). Oxidation of diclofenac to reactive intermediates by neutrophils, myeloperoxidase, and hypochlorous acid. Chemical Research in Toxicology, 10: 414-419.